136 related articles for article (PubMed ID: 22790126)
21. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.
Fischer A; Kong AM; Swigris JJ; Cole AL; Raimundo K
J Rheumatol; 2018 Feb; 45(2):235-241. PubMed ID: 29142033
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for malignancy in systemic sclerosis patients.
Kaşifoğlu T; Yaşar Bilge Ş; Yıldız F; Özen G; Pehlivan Y; Yılmaz N; Tarhan F; Yılmaz S; Küçük A; Emmungil H; Koca SS; Çınar M; Direskeneli H; Erken E; Can G; Özmen M; Gönüllü E; Kisacik B; Aksu K; Karadağ O; Kasifoglu N; Arslantas D; Sahin F; Keser G; Yavuz S; Birlik M; Onat AM
Clin Rheumatol; 2016 Jun; 35(6):1529-33. PubMed ID: 27118199
[TBL] [Abstract][Full Text] [Related]
23. Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.
Ebata S; Yoshizaki A; Fukasawa T; Miura S; Takahashi T; Sumida H; Asano Y; Sato S
J Dermatol; 2019 Nov; 46(11):1006-1013. PubMed ID: 31502326
[TBL] [Abstract][Full Text] [Related]
24. Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study.
Bauer PR; Schiavo DN; Osborn TG; Levin DL; St Sauver J; Hanson AC; Schroeder DR; Ryu JH
Chest; 2013 Aug; 144(2):571-577. PubMed ID: 23450327
[TBL] [Abstract][Full Text] [Related]
25. Incidence of cancer among patients with systemic sclerosis.
Rosenthal AK; McLaughlin JK; Gridley G; Nyrén O
Cancer; 1995 Sep; 76(5):910-4. PubMed ID: 8625197
[TBL] [Abstract][Full Text] [Related]
26. Risk of cancer in patients with scleroderma: a population based cohort study.
Hill CL; Nguyen AM; Roder D; Roberts-Thomson P
Ann Rheum Dis; 2003 Aug; 62(8):728-31. PubMed ID: 12860727
[TBL] [Abstract][Full Text] [Related]
27. Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study.
Lopez L; Barnetche T; Galli G; Seneschal J; Blanchard E; Shipley E; Pellegrin JL; Lazaro E; Constans J; Duffau P; Schaeverbeke T; Richez C; Kostine M; Truchetet ME
Joint Bone Spine; 2023 May; 90(3):105555. PubMed ID: 36842760
[TBL] [Abstract][Full Text] [Related]
28. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
[TBL] [Abstract][Full Text] [Related]
29. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, incidence, and risk factors of malignancy in patients with rheumatoid arthritis: a nationwide cohort study from Korea.
Ko KM; Moon SJ
Korean J Intern Med; 2023 Jan; 38(1):113-124. PubMed ID: 34407599
[TBL] [Abstract][Full Text] [Related]
31. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
[TBL] [Abstract][Full Text] [Related]
32. Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis.
Hurtubise R; Hudson M; Gyger G; Wang M; Steele RJ; Baron M; ; Hoa S
Respir Med; 2021; 185():106482. PubMed ID: 34089970
[TBL] [Abstract][Full Text] [Related]
33. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
34. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.
Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W
Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397
[TBL] [Abstract][Full Text] [Related]
35. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
[TBL] [Abstract][Full Text] [Related]
37. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
38. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
[TBL] [Abstract][Full Text] [Related]
39. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
40. Malignancy in Crohn's disease: incidence and clinical characteristics in Japan.
Mizushima T; Ohno Y; Nakajima K; Kai Y; Iijima H; Sekimoto M; Nishida T; Nezu R; Ito T; Doki Y; Mori M
Digestion; 2010; 81(4):265-70. PubMed ID: 20134166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
